The findings were statistically significant and corroborated the findings of TCGA, indicating elevated CLDN5 was associated with lymph node metastasis in patients with gastric cancer, with clinical staging being lymph node metastasis. This evidence concerns the gene CLDN5 and metastatic malignant neoplasm in the lymph nodes.